Norwest Venture Partners XIV
Latest statistics and disclosures from Norwest Venture Partners XIV's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Impel Neuropharma, OPEN, and represent 100.00% of Norwest Venture Partners XIV's stock portfolio.
- Reduced shares in these 1 stock: OPEN (-$46M).
- Norwest Venture Partners XIV was a net seller of stock by $-46M.
- Norwest Venture Partners XIV has $60M in assets under management (AUM), dropping by -30.26%.
- Central Index Key (CIK): 0001842721
Tip: Access up to 7 years of quarterly data
Positions held by Norwest Venture Partners XIV consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Norwest Venture Partners XIV
Norwest Venture Partners XIV holds 2 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Impel Neuropharma | 62.1 | $38M | 3.1M | 12.18 |
|
|
| Opendoor Technologies (OPEN) | 37.9 | $23M | -66% | 1.1M | 20.53 |
|
Past Filings by Norwest Venture Partners XIV
SEC 13F filings are viewable for Norwest Venture Partners XIV going back to 2020
- Norwest Venture Partners XIV 2021 Q3 filed Oct. 27, 2021
- Norwest Venture Partners XIV 2021 Q2 filed Aug. 10, 2021
- Norwest Venture Partners XIV 2021 Q1 filed April 21, 2021
- Norwest Venture Partners XIV 2020 Q4 filed Feb. 16, 2021